首页> 外文期刊>慢性疾病与转化医学:英文版 >Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
【24h】

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors

机译:免疫检查点抑制剂引起的胃肠道不良事件的处理

获取原文
获取原文并翻译 | 示例
           

摘要

IntroductionCancer cells can avoid being recognized and destroyed by the immune system by activating im-mune checkpoints, such as cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and the programmed death-1 (PD-1) receptor and its ligand PD-L1.
机译:简介癌细胞可以通过激活免疫检查点来避免被免疫系统识别和破坏,例如细胞毒性T淋巴细胞相关抗原4(CTLA4)和程序性死亡1(PD-1)受体及其配体PD-L1。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号